TABLE 1.
Circulating miRNAs and their possible/identified targets in different gastrointestinal disorders.
Circulating miRNAs | Diseases | Up/down | Potential/identified target genes | Roles | References |
miR-25-3p | CRC | Up | KLF2, KLF4 | Promoting CRC vascular permeability and angiogenesis | Zeng et al., 2018 |
miR-106b-3p | CRC | Up | DLC-1 | Promoting CRC metastasis | Liu et al., 2020 |
miR-1229 | CRC | Up | HIPK2 | Promoting CRC angiogenesis | Hu et al., 2019 |
miR-590-5p | CRC | Down | NF90 | Inhibiting CRC angiogenesis and metastasis | Zhou Q. et al., 2016 |
miR-622 | CRC | Down | CXCR4, K-Ras | Inhibiting CRC angiogenesis and metastasis | Fang et al., 2016, 2019 |
miR-382 | CRC | Down | NR2F2 | Inhibiting CRC cell growth and invasion | Zhou B. et al., 2016 |
miR-409-3p | CRC | Down | Beclin-1 | Inhibiting autophagy | Tan et al., 2016 |
miR-223 | IBD | Up | CLDN8 | Dysfunction of the intestinal epithelial barrier | Wang et al., 2016 |
miR-21 | IBD | Up | RhoB | Dysfunction of the intestinal epithelial barrier | Yang et al., 2013 |
miR-320 | IBD | Down | NOD2 | Disruption of immune homeostasis | Pierdomenico et al., 2016 |
miR-31 | IBD | Up | IL6st, IL7r, IL17ra | Suppressing inflammation | Tian et al., 2019 |
Up and down indicate upregulated and downregulated circulating miRNA expression levels in diseased tissues compared with normal tissues, respectively. Roles, roles of miRNAs in the pathogenesis of gastrointestinal disorders; CRC, colorectal cancer; IBD, inflammatory bowel disease.